Ovation Science Inc.
OVATF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2 | $1 | $1 | $3 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $1 | $1 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 82.8% | -55.2% | -38.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 75.7% | 87.4% | 97.8% | 83.6% |
| EBITDA | -$0 | -$1 | -$1 | -$2 |
| % Margin | -357% | -1,257.5% | -569.5% | -674.1% |
| Net Income | -$0 | -$1 | -$1 | -$2 |
| % Margin | -402.9% | -1,312.9% | -574.8% | -1,064.1% |
| EPS Diluted | -0.013 | -0.027 | -0.027 | -0.082 |
| % Growth | 51.5% | 0.7% | 66.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$1 | -$1 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$1 | -$1 |